# A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris

> **NCT00845481** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 24 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Daivobet® ointment
- **DRUG:** Betnovat® ointment
- **DRUG:** Diprosalic ointment
- **DRUG:** Dermovat ointment
- **DRUG:** Elocon ointment
- **DRUG:** Daivobet® ointment vehicle

## Key facts

- **NCT ID:** NCT00845481
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845481, "A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00845481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*